Genetic Technologies (GENE) Institutional Ownership $0.76 0.00 (0.00%) As of 05/20/2025 Add Compare Share Share Ownership Stock AnalysisChartCompetitorsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Genetic Technologies (NASDAQ:GENE)CurrentInstitutional OwnershipPercentage0.63%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$210KNumber ofInstitutional Sellers(last 12 months)0 Get GENE Insider Trade Alerts Want to know when executives and insiders are buying or selling Genetic Technologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GENE Institutional Buying and Selling by Quarter Genetic Technologies Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024 Armistice Capital LLC140,000$210K0.0%N/A3.177% 5/1/2024 BNP Paribas Financial Markets9,100$26K0.0%N/A0.236% 11/7/2023 Scarborough Advisors LLC548,372$417K0.0%+5,054.8%2.850% 3/6/2023 OLD Mission Capital LLC70,241$65K0.0%+109.7%0.365% 11/22/2022 Continental Investors Services Inc.32,000$47K0.0%N/A0.208% 11/14/2022 OLD Mission Capital LLC33,499$39K0.0%N/A0.218% 8/13/2021 Jump Financial LLC10,657$45K0.0%N/A0.069% 8/11/2021 Susquehanna Fundamental Investments LLC36,172$154K0.0%-44.0%0.235% 5/17/2021 Hennion & Walsh Asset Management Inc.10,072$42K0.0%N/A0.067% 5/17/2021 Goldman Sachs Group Inc.21,602$90K0.0%N/A0.144% (Data available from 1/1/2016 forward) GENE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GENE shares? During the previous two years, the following institutional investors and hedge funds held shares of Genetic Technologies shares: Scarborough Advisors LLC ($417K), and Armistice Capital LLC ($210K), BNP Paribas Financial Markets ($26K).Learn more on GENE's institutional investors. What percentage of Genetic Technologies stock is owned by institutional investors? 0.63% of Genetic Technologies stock is owned by institutional investors. Learn more on GENE's institutional investor holdings. Which institutional investors have been buying Genetic Technologies stock? The following institutional investors have purchased Genetic Technologies stock in the last 24 months: Scarborough Advisors LLC ($537.73K), Armistice Capital LLC ($140K), and BNP Paribas Financial Markets ($9.10K). How much institutional buying is happening at Genetic Technologies? Institutional investors have bought a total of 686,834 shares in the last 24 months. This purchase volume represents approximately $2.29M in transactions. Related Companies NKGN Major Shareholders PRPH Major Shareholders ME Major Shareholders IBIO Major Shareholders FLGC Major Shareholders SYBX Major Shareholders MRKR Major Shareholders NXTC Major Shareholders AYTU Major Shareholders CLDI Major Shareholders This page (NASDAQ:GENE) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredAI Bloodbath Coming on June 1st?If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genetic Technologies Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Genetic Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GENE Stock Free GENE Stock Alerts